June Lee
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
June Lee est membre du conseil d'administration d'Eledon Pharmaceuticals, Inc. et présidente du Council of Korean Americans. Au cours de sa carrière, elle a occupé les postes de directrice du développement et de vice-présidente exécutive chez MyoKardia, Inc., de directrice médicale chez Genentech, Inc. et de directrice de la recherche translationnelle et du programme catalyseur à l'université de Californie, à San Francisco, ainsi que de professeur à l'université des sciences et de la médecine de Californie. June Lee a obtenu un diplôme de premier cycle à l'école de médecine de l'université Johns Hopkins et un doctorat à l'école de médecine de l'UC Davis.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 28/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
ABIVAX SA -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/12/2020 |
| TENAYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 19/11/2021 |
| ABIVAX | Directeur/Membre du Conseil | 11/07/2023 |
| NKGEN BIOTECH KOREA CO., LTD. | Directeur/Membre du Conseil | 21/11/2025 |
Council of Korean Americans | Directeur/Membre du Conseil | - |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Directeur/Membre du Conseil | - |
University of California Drug Discovery Consortium | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | 30/11/2024 |
| CINCOR PHARMA, INC. | Directeur/Membre du Conseil | 24/02/2023 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 15 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
UC Davis School of Medicine
UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
UCSF School of Medicine
UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Council of Korean Americans | |
NKMAX Co., Ltd. (South korea)
NKMAX Co., Ltd. (South korea) BiotechnologyHealth Technology Manufactures biological products | Health Technology |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
CinCor Pharma, Inc.
CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
University of California Drug Discovery Consortium |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national